Edition:
United States

Medivir AB (MVIRb.ST)

MVIRb.ST on Stockholm Stock Exchange

17.10SEK
10:43am EDT
Change (% chg)

-0.26kr (-1.50%)
Prev Close
17.36kr
Open
17.18kr
Day's High
17.18kr
Day's Low
16.90kr
Volume
6,374
Avg. Vol
55,119
52-wk High
50.70kr
52-wk Low
16.82kr

Chart for

About

Medivir AB is a Sweden-based pharmaceutical research and development company with focus on oncology. The Company specializes in protease inhibitor design and nucleoside and nucleotide science, applying it to development of therapies for cancers with unmet medical need. The Company's clinical pipeline consists of remetinostat, a... (more)

Overall

Beta: 1.08
Market Cap(Mil.): kr421.64
Shares Outstanding(Mil.): 24.29
Dividend: --
Yield (%): --

Financials

  MVIRb.ST Industry Sector
P/E (TTM): -- 99.54 58.10
EPS (TTM): -14.71 -- --
ROI: -83.77 7.80 12.12
ROE: -85.29 7.82 13.24

Earnings vs. Estimates